Delivery Order V797D60717-VA77017J1535
Award Date
9/7/17
Potential Completion Date
9/18/17
Potential Value
$198K
Funding Federal Agency
Veterans Integrated Service Network 12
Contracting Federal Agency
Veterans Integrated Service Network 15
Awardee
Kaleo, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Richmond, VA 23219, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Kaleo, Inc., a pharmaceutical company specializing in auto-injector technologies for life-saving medications. The contract was awarded by the Department of Veterans Affairs (VA) for the delivery of naloxone auto-injectors. The contract has a ceiling value of $175,000.00 and is a delivery order under the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The contract is a firm fixed-price type and does not have a set-aside designation. Kaleo,...
This is a $301,540.00 firm fixed-price delivery order contract awarded by the Department of Veterans Affairs to Kaleo, Inc. for the provision of NALOXONE INJECTORS. The contract is under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and has an ultimate completion date of December 16, 2016. Kaleo, Inc. is a pharmaceutical company specializing in innovative auto-injector technologies for life-saving medications, and this award demonstrates the company's role in supplying...
This is a federal contract award to Kaleo, Inc., a pharmaceutical company specializing in auto-injector technologies for life-saving medications. The $90,000.00 Firm Fixed Price delivery order was issued by the Department of Veterans Affairs (VA), specifically the Veterans Integrated Service Network 12, for the procurement of NALOXONE 2MG AUTOINJECTOR KIT. The contract is not set aside for any particular business classification. Kaleo, Inc. has established itself as a key supplier of critical...
This federal contract award to Kaleo, Inc. for NALOXONE AUTO INJECTORS has a ceiling value of $452,310.00. The contract was awarded by the Department of Veterans Affairs (VA), specifically the Veterans Integrated Service Network 12, and is a firm fixed-price purchase order with an ultimate completion date of August 17, 2016. The contract does not have a set-aside designation. Kaleo, Inc. is a pharmaceutical company specializing in auto-injector technologies for life-saving medications, and...
This is a federal contract award from the U.S. Department of Veterans Affairs (VA) to Kaleo, Inc., a pharmaceutical company specializing in auto-injector technologies for critical medications. The $138,708.40 firm fixed-price delivery order is for the supply of naloxone hydrochloride injection, a medication used to treat opioid overdoses. The contract is not set aside and is awarded under Kaleo's existing Indefinite Delivery Vehicle (IDV) agreements with the VA, including a $225,000 Federal...
This federal contract award to Kaleo, Inc. for $452,310.00 was issued by the Veterans Integrated Service Network 12 (VISN 12), a part of the U.S. Department of Veterans Affairs (VA). The contract is for the delivery of NALOXONE 0.4MG/0.4ML AUTOINJECTOR,KIT, which are critical medical countermeasures used to address the opioid crisis and support emergency response efforts. Kaleo, Inc. is a pharmaceutical company that specializes in innovative auto-injector technologies for life-saving...
This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 12 to Kaleo, Inc., a small business manufacturer of pharmaceutical auto-injector devices. The $452,310.00 contract is to provide naloxone auto-injectors, which are critical life-saving medications used to address the opioid crisis. Kaleo is a key supplier of emergency response products to federal agencies, having received multiple awards from the Department of Health and...
This federal contract award was issued by the Department of Veterans Affairs (VA) Veterans Health Administration to Emergent Devices, Inc., a for-profit manufacturer of pharmaceuticals and medical devices, to provide naloxone nasal spray. Naloxone is a medication that rapidly reverses opioid overdoses and treats substance abuse. The $946,261.44 firm-fixed-price delivery order was placed against Emergent Devices' Federal Supply Schedule 65 IB contract, which furnishes drugs and hematology...
The Department of Veterans Affairs Veterans Health Administration awarded a $672,672.00 Firm Fixed Price Delivery Order to Emergent Devices, Inc., a for-profit manufacturer, for the provision of the opioid overdose reversal medication naloxone. This order is under Emergent Devices' existing Federal Supply Schedule 65 IB contract for pharmaceuticals and drugs, which runs through August 2028. The contract has no set-aside designation. Emergent Devices has previously received sub-awards from...
The Department of Veterans Affairs Veterans Health Administration awarded a $934,410.48 firm fixed-price delivery order to Emergent Devices, Inc. for the provision of naloxone nasal spray. Naloxone is a medication that rapidly reverses opioid overdoses and treats substance abuse. The contract is under the Pharmaceuticals and Drugs Federal Supply Schedule, which allows Veterans Integrated Service Network 12 to procure pharmaceuticals through a streamlined vehicle. Emergent Devices, a for-profit...